As of Jul 21
| -2.25 / -0.96%|
The 4 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 252.50, with a high estimate of 275.00 and a low estimate of 245.00. The median estimate represents a +9.03% increase from the last price of 231.59.
The current consensus among 4 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.